PLUMESSENCE LIMITED
Company number 15042852 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
PLUMESSENCE LIMITED - Analysis Report
Company Number: 15042852
Analysis Date: 2025-07-29 16:51 UTC
Financial Health Assessment of PlumEssence Limited as of 31 July 2024
1. Financial Health Score: B
Explanation:
PlumEssence Limited exhibits a sound financial footing typical for a newly incorporated micro-entity. The company shows positive net current assets and net assets, indicating a stable balance sheet with no immediate liquidity distress. The score "B" reflects a healthy startup phase with good working capital but limited financial history and scale, which naturally constrains a higher grade until further operational data is available.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 6,475 | Represents liquid or near-liquid resources; indicates the company has accessible resources. |
| Current Liabilities | 1,697 | Short-term obligations; relatively low, manageable given current assets. |
| Net Current Assets | 4,778 | Positive working capital ("healthy cash flow buffer") suggesting short-term liquidity strength. |
| Total Assets Less Current Liabilities | 4,778 | Total resources available after settling short-term debts; a positive figure is a good sign. |
| Net Assets (Shareholders’ Funds) | 4,778 | Represents owners’ equity; positive and equal to net current assets, no long-term liabilities. |
| Employees | 1 (average) | Very small scale, typical for micro-company, low overheads. |
| Company Age | ~1 year | Early stage; limited operational history to assess trends or profitability. |
3. Diagnosis: What the Financial Data Reveals About Business Health
Liquidity & Solvency: The company shows positive net current assets of £4,778, indicating it can comfortably cover its short-term liabilities. This “healthy cash flow” symptom points to no immediate liquidity distress.
Capital Structure: Equity equals net assets with no reported long-term borrowings or liabilities, reflecting a clean balance sheet typical of a new start-up without debt burden.
Operational Scale: With just one employee and limited asset base, the business operates at a micro scale. This is consistent with the micro-entity filing status and the nature of consultancy/bookkeeping services identified by SIC codes.
Profitability & Cash Flow: No profit and loss data is provided, but the absence of audit requirements and the micro-entity exemption imply modest turnover and expenses. The company’s ability to maintain positive net assets in its first year is a positive “vital sign.”
Governance & Control: Single director and sole shareholder, which simplifies decision-making but also concentrates control risk. The director’s background as a management consultant aligns well with the company’s business activities.
Growth Prospects: As a start-up, the company’s financial “vital signs” are stable, but the prognosis depends on future revenue growth, expense management, and market demand. The absence of debt provides flexibility to invest or withstand initial operational challenges.
4. Recommendations: Specific Actions to Improve Financial Wellness
Monitor Cash Flow Regularly: Maintain healthy cash reserves to cover operating expenses and unexpected costs. Regular cash flow forecasting will help spot any early “symptoms” of liquidity issues.
Build Revenue Streams: Focus on expanding client base and service offerings aligned with existing SIC codes (management consultancy, bookkeeping, education). This will strengthen profitability and operational scale.
Maintain Strong Financial Controls: Even as a micro-entity, robust bookkeeping and timely filing will prevent compliance risks and support strategic decision-making.
Consider Formal Profit & Loss Tracking: Although exempt from audit, internal tracking of income and expenses will provide insights to manage costs and optimize margins.
Plan for Growth & Funding: If expansion is anticipated, evaluate financing options such as equity injection or small business loans to fuel growth while maintaining solvency.
Risk Management: With a sole director/shareholder, consider succession planning or adding advisory roles to reduce concentration risk and enhance governance.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.